Szejko, N.; Abusrair, A.; Pasierski, T.; Schmitt, S.; Cramer, C.; Pietrzykowski, T.; Dunalska, A.; Saramak, K.; Śmiłowska, K.; Serranova, T.;
et al. Placebo in Functional Neurological Disorders: Promise and Controversy. Healthcare 2025, 13, 2863.
https://doi.org/10.3390/healthcare13222863
AMA Style
Szejko N, Abusrair A, Pasierski T, Schmitt S, Cramer C, Pietrzykowski T, Dunalska A, Saramak K, Śmiłowska K, Serranova T,
et al. Placebo in Functional Neurological Disorders: Promise and Controversy. Healthcare. 2025; 13(22):2863.
https://doi.org/10.3390/healthcare13222863
Chicago/Turabian Style
Szejko, Natalia, Ali Abusrair, Tomasz Pasierski, Simon Schmitt, Catharina Cramer, Tomasz Pietrzykowski, Anna Dunalska, Kamila Saramak, Katarzyna Śmiłowska, Tereza Serranova,
and et al. 2025. "Placebo in Functional Neurological Disorders: Promise and Controversy" Healthcare 13, no. 22: 2863.
https://doi.org/10.3390/healthcare13222863
APA Style
Szejko, N., Abusrair, A., Pasierski, T., Schmitt, S., Cramer, C., Pietrzykowski, T., Dunalska, A., Saramak, K., Śmiłowska, K., Serranova, T., & Müller-Vahl, K. R.
(2025). Placebo in Functional Neurological Disorders: Promise and Controversy. Healthcare, 13(22), 2863.
https://doi.org/10.3390/healthcare13222863